DE | Accessible presentation
Translations are powered by AI

The most important investments of the third quarter of 2024

Helsing, Egym, Catalym – many Munich-based startups successfully raised funding in the third quarter of this year. This photo gallery provides an overview of the largest investments in the third quarter of 2024.

October 8, 2024 4 min reading time

Scirhom
63 million euros for Scirhom: Scirhom secures 63 million euros in an extended Series A financing round. The round is led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners. Existing investors such as High-Tech Gründerfonds (HTGF) and PhiFund Ventures are also participating. Bayern Kapital is joining as a new investor. The new capital will be used to advance and expand Scirhom's innovative therapeutic strategy in the field of autoimmune diseases. The first clinical trial with SR-878, a highly specific monoclonal antibody against the target molecule iRhom2, is scheduled to begin in the second half of 2024, according to the company. (Image: Scirhom)
read more ↓